Cormorant Asset Management, LP Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$2.0T
Holdings
84
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (84 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —BIOTIE THERAPIES OYJ | 50,000 | $1.3T | 66.57% | |
| 2 | —ALDER BIOPHARMACEUTICALS INC | 1,497,475 | $36.7B | 1.85% | |
| 3 | HRTXHERON THERAPEUTICS INC | 1,750,000 | $33.2B | 1.68% | |
| 4 | SG7SAGE THERAPEUTICS INC | 945,000 | $30.3B | 1.53% | |
| 5 | OMEROMEROS CORP | 1,960,000 | $30.1B | 1.52% | |
| 6 | NKTREURNEKTAR THERAPEUTICS | 2,000,000 | $27.5B | 1.39% | |
| 7 | NVROEURNEVRO CORP | 485,386 | $27.3B | 1.38% | |
| 8 | ALKSALKERMES PLC | 700,000 | $23.9B | 1.21% | |
| 9 | NBIXNEUROCRINE BIOSCIENCES INC | 603,900 | $23.9B | 1.21% | |
| 10 | EGRXEAGLE PHARMACEUTICALS INC | 500,000 | $20.3B | 1.02% | |
| 11 | DVAXDYNAVAX TECHNOLOGIES CORP | 975,000 | $18.8B | 0.95% | |
| 12 | —PROTEOSTASIS THERAPEUTICS IN | 1,726,599 | $16.6B | 0.84% | |
| 13 | ALNYALNYLAM PHARMACEUTICALS INC | 245,000 | $15.4B | 0.78% | |
| 14 | —PORTOLA PHARMACEUTICALS INC | 700,000 | $14.3B | 0.72% | |
| 15 | —QUOTIENT LTD | 1,519,100 | $13.4B | 0.67% | |
| 16 | MGNXMACROGENICS INC | 700,000 | $13.1B | 0.66% | |
| 17 | CLLSCELLECTIS S A | 469,145 | $12.9B | 0.65% | |
| 18 | —TESARO INC | 291,250 | $12.8B | 0.65% | |
| 19 | —CHINA BIOLOGIC PRODS INC | 111,500 | $12.8B | 0.64% | |
| 20 | ACRSACLARIS THERAPEUTICS INC COM | 647,944 | $12.3B | 0.62% | |
| 21 | CHRSCOHERUS BIOSCIENCES INC | 569,130 | $12.1B | 0.61% | |
| 22 | ARDXARDELYX INC | 1,481,075 | $11.5B | 0.58% | |
| 23 | —VITAE PHARMACEUTICALS INC | 1,735,000 | $11.5B | 0.58% | |
| 24 | SRNESORRENTO THERAPEUTICS INC | 2,095,334 | $11.3B | 0.57% | |
| 25 | NERVGBPMINERVA NEUROSCIENCES INC | 1,752,946 | $10.8B | 0.54% | |
| 26 | MRTXEURMIRATI THERAPEUTICS INC | 495,356 | $10.6B | 0.53% | |
| 27 | DC4DEXCOM INC | 153,000 | $10.4B | 0.52% | |
| 28 | CELGCELGENE CORP | 100,000 | $10.0B | 0.50% | |
| 29 | —ROCKWELL MEDICAL INC | 1,105,000 | $8.3B | 0.42% | |
| 30 | NVAXNOVAVAX INC | 1,600,000 | $8.3B | 0.42% | |
| 31 | COLLCOLLEGIUM PHARMACEUTICAL INC | 450,000 | $8.2B | 0.41% | |
| 32 | —MYOKARDIA INC | 753,388 | $8.1B | 0.41% | |
| 33 | —ADVAXIS INC | 800,000 | $7.2B | 0.36% | |
| 34 | RAREULTRAGENYX PHARMACEUTICAL IN | 109,500 | $6.9B | 0.35% | |
| 35 | —CELATOR PHARMACEUTICALS INC | 620,000 | $6.8B | 0.35% | |
| 36 | —LIPOCINE INC NEW | 666,666 | $6.8B | 0.34% | |
| 37 | MCRB1EURSERES THERAPEUTICS INC | 250,000 | $6.6B | 0.34% | |
| 38 | AGENEURAGENUS INC | 1,559,000 | $6.5B | 0.33% | |
| 39 | —PFENEX INC | 624,900 | $6.1B | 0.31% | |
| 40 | —FORWARD PHARMA A/S | 335,068 | $5.7B | 0.29% | |
| 41 | WVEWAVE LIFE SCIENCES LTD | 392,079 | $5.4B | 0.27% | |
| 42 | XLRNACCELERON PHARMA INC | 200,000 | $5.3B | 0.27% | |
| 43 | CTMXCYTOMX THERAPEUTICS INC | 371,023 | $4.8B | 0.24% | |
| 44 | SCTLRECRO PHARMA INC | 780,000 | $4.7B | 0.23% | |
| 45 | —ZYNERBA PHARMACEUTICALS INC | 475,035 | $4.5B | 0.23% | |
| 46 | —ACHILLION PHARMACEUTICALS IN | 500,000 | $3.9B | 0.19% | |
| 47 | —DERMIRA INC | 170,000 | $3.5B | 0.18% | |
| 48 | —AGILE THERAPEUTICS INC | 557,053 | $3.5B | 0.17% | |
| 49 | —CELYAD SA | 75,000 | $3.3B | 0.17% | |
| 50 | —INTEC PHARMA LTD JERUSALEM | 800,000 | $3.3B | 0.17% | |
| 51 | —EPIZYME INC | 266,250 | $3.2B | 0.16% | |
| 52 | —APTOSE BIOSCIENCES INC | 1,081,867 | $3.2B | 0.16% | |
| 53 | —KITE PHARMA INC | 68,800 | $3.2B | 0.16% | |
| 54 | BCRXBIOCRYST PHARMACEUTICALS | 1,080,000 | $3.1B | 0.15% | |
| 55 | SNDXSYNDAX PHARMACEUTICALS INC. | 214,419 | $2.9B | 0.14% | |
| 56 | ATRAGBXATARA BIOTHERAPEUTICS INC | 150,000 | $2.9B | 0.14% | |
| 57 | —CONTRAFECT CORP | 834,406 | $2.8B | 0.14% | |
| 58 | —BELLICUM PHARMACEUTICALS INC | 300,000 | $2.8B | 0.14% | |
| 59 | —LION BIOTECHNOLOGIES INC | 499,815 | $2.5B | 0.13% | |
| 60 | —IMMUNE DESIGN CORP | 189,000 | $2.5B | 0.12% | |
| 61 | —EPIRUS BIOPHARMACEUTICALS IN | 896,600 | $2.4B | 0.12% | |
| 62 | —OVASCIENCE INC | 252,180 | $2.4B | 0.12% | |
| 63 | —CURIS INC | 1,162,400 | $1.9B | 0.09% | |
| 64 | RGNXREGENXBIO INC | 156,741 | $1.7B | 0.09% | |
| 65 | GLYCEURGLYCOMIMETICS INC | 283,555 | $1.7B | 0.09% | |
| 66 | —AQUINOX PHARMACEUTICALS INC | 150,000 | $1.3B | 0.07% | |
| 67 | AM6AMICUS THERAPEUTICS INC | 150,000 | $1.3B | 0.06% | |
| 68 | —TETRALOGIC PHARMACEUTICALS C | 5,000,000 | $1.1B | 0.06% | |
| 69 | ASNDASCENDIS PHARMA A S | 61,500 | $1.1B | 0.06% | |
| 70 | —AVEO PHARMACEUTICALS INC | 1,087,715 | $1.0B | 0.05% | |
| 71 | —GENVEC INC | 1,176,235 | $948.0M | 0.05% | |
| 72 | PVCTPROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $836.0M | 0.04% | |
| 73 | VCYTVERACYTE INC | 137,990 | $745.0M | 0.04% | |
| 74 | NSTGEURNANOSTRING TECHNOLOGIES INC | 40,000 | $609.0M | 0.03% | |
| 75 | —HTG MOLECULAR DIAGNOSTICS IN | 201,000 | $577.0M | 0.03% | |
| 76 | —NEOS THERAPEUTICS INC | 50,000 | $540.0M | 0.03% | |
| 77 | —THRESHOLD PHARMACEUTICALS INC | 1,000,000 | $460.0M | 0.02% | |
| 78 | —PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $440.0M | 0.02% | |
| 79 | —PRONAI THERAPEUTICS INC | 53,153 | $358.0M | 0.02% | |
| 80 | —APPLIED GENETIC TECHNOL CORP | 17,110 | $239.0M | 0.01% | |
| 81 | —REGULUS THERAPEUTICS INC | 30,656 | $212.0M | 0.01% | |
| 82 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 25,000 | $203.0M | 0.01% | |
| 83 | —CELLECTAR BIOSCIENCES INC | 52,999 | $180.0M | 0.01% | |
| 84 | —CELLECTAR BIOSCIENCES INC | 52,999 | $38.0M | 0.00% |